Boston Scientific CRM Corp Guidant Contak Renewal 3 CRT-D Model H170; 3CRT-D, Model H175; 3HE CRT-D, Model H177; 3HE CRT-D, Model H179; 4CRT-D REF H190; 4CRT-D REF H195; 4HE CRT-D REF H197; 4HE CRT-D REF H199; 4AVT CRT D, REF M177; 4AVT HE CRT-D REF 179. Cardiac Resynchronization Therapy Defibrillator, Sterile EO, Guidant Corporation, 4100 Hamline Avenue North, St Paul, MN 55112-5798. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Guidant Contak Renewal 3 CRT-D Model H170; 3CRT-D, Model H175; 3HE CRT-D, Model H177; 3HE CRT-D, Model H179; 4CRT-D REF H190; 4CRT-D REF H195; 4HE CRT-D REF H197; 4HE CRT-D REF H199; 4AVT CRT D, REF M177; 4AVT HE CRT-D REF 179. Cardiac Resynchronization Therapy Defibrillator, Sterile EO, Guidant Corporation, 4100 Hamline Avenue North, St Paul, MN 55112-5798. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support.
Brand
Boston Scientific CRM Corp
Lot Codes / Batch Numbers
SERIAL NUMBERS FOR MODEL #H170 : 361904, 363420, 363895, 364293, 364294, 364349, 364350, 364470, 364480, 364485, 364486, 364494, 364510, 364539, 364617 and 364621, and SERIAL NUMBERS MODEL #H175: 312616, 312962, 312965, 312973, 313064, 315207, 315209, 315212, 315213, 315219, 315227, 315238, 315248, 315251, 315265, 315398, 315431, 315446, 316045, 316064 and 316123, and SERIAL NUMBERS MODEL #H177: 281692, 282937, 284803, 284874, 284896, 285009, 285019, 285091, 285110, 285111, 285120, 285134 285332 and 285357, and SERIAL NUMBERS MODEL #H179: 111439, 112977, 113822, 113910, 114275, 114375, 114394, 114488, 114503, 114506, 114515, 114523, 114652, 114680, 114682 and 114714, and SERIAL NUMBERS MODEL #H190: 312166, 311764, 311803, 311894, 312164 and 312177, and SERIAL NUMBERS MODEL #H195: 352084, 353252, 353389, 351230, 353157 and 353388, and SERIAL NUMBERS MODEL #H197: 310113, 310253, 310651, 310335, 310337, 310339, 310342, 310357, 310361, 310442, 310464, 310465, 310518, 310660, 310691, 310696, 310814, 310933 and 311096, and SERIAL NUMBERS MODEL #H199: 321405, 321060, 321415, 321423, 321478, 321489, 321494, 321498 and 321689, and SERIAL NUMBERS MODEL #M177: 200050 and 200051, and SERIAL NUMBERS MODEL #M179: 200098, 200099 and 200033.
Products Sold
SERIAL NUMBERS FOR MODEL #H170 : 361904, 363420, 363895, 364293, 364294, 364349, 364350, 364470, 364480, 364485, 364486, 364494, 364510, 364539, 364617 and 364621; and SERIAL NUMBERS MODEL #H175: 312616, 312962, 312965, 312973, 313064, 315207, 315209, 315212, 315213, 315219, 315227, 315238, 315248, 315251, 315265, 315398, 315431, 315446, 316045, 316064 and 316123; and SERIAL NUMBERS MODEL #H177: 281692, 282937, 284803, 284874, 284896, 285009, 285019, 285091, 285110, 285111, 285120, 285134 285332 and 285357; and SERIAL NUMBERS MODEL #H179: 111439, 112977, 113822, 113910, 114275, 114375, 114394, 114488, 114503, 114506, 114515, 114523, 114652, 114680, 114682 and 114714; and SERIAL NUMBERS MODEL #H190: 312166, 311764, 311803, 311894, 312164 and 312177; and SERIAL NUMBERS MODEL #H195: 352084, 353252, 353389, 351230, 353157 and 353388; and SERIAL NUMBERS MODEL #H197: 310113, 310253, 310651, 310335, 310337, 310339, 310342, 310357, 310361, 310442, 310464, 310465, 310518, 310660, 310691, 310696, 310814, 310933 and 311096; and SERIAL NUMBERS MODEL #H199: 321405, 321060, 321415, 321423, 321478, 321489, 321494, 321498 and 321689; and SERIAL NUMBERS MODEL #M177: 200050 and 200051; and SERIAL NUMBERS MODEL #M179: 200098, 200099 and 200033.
Boston Scientific CRM Corp is recalling Guidant Contak Renewal 3 CRT-D Model H170; 3CRT-D, Model H175; 3HE CRT-D, Model H177; 3HE CRT-D, Mod due to In April 2007, Boston Scientific CRM communicated with physicians regarding the potential for reduced Elective Replacement Indicator (ERI) to Battery . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
In April 2007, Boston Scientific CRM communicated with physicians regarding the potential for reduced Elective Replacement Indicator (ERI) to Battery End of Life (EOL) time in a subset of implantable defibrillators due to degradation of a low-voltage capacitor. Since that time, the April 2007 advisory population has not experienced any clinically significant changes to either the rate of occurrenc
Recommended Action
Per FDA guidance
Boston Scientific CRM notified Doctors via sales representatives of an "Urgent Medical Device Information" letter dated March 4, 2009. The letter described the problem and included Description of Issue, Rate of Occurrence, Patient Management Recommendations, Devices Affected, Warranty Program & Further Information. A Boston Scientific " Product Advisory" letter dated March 4, 2009, was also made available to physicians to distribute to patients. The letter informed the patient that their defibrillator was included in a group of devices that might experience a performance issue. For further questions, Contact Boston Scientific CRM at 1-800-227-3422.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WV, WI, WY, DC, PR
Page updated: Jan 10, 2026